n-3 fatty acids in the treatment of diabetic patients: biological rationale and clinical data.
De Caterina
Raffaele
R
Institute of Cardiology, G. d'Annunzio University, Chieti, Italy. rdecater@unich.it
Madonna
Rosalinda
R
Bertolotto
Alessandra
A
Schmidt
Erik Berg
EB
D001786:Blood Glucose / Q000187:drug effects / Q000378:metabolism; D003327:Coronary Disease / Q000517:prevention & control; D003920:Diabetes Mellitus / Q000097:blood / Q000188:drug therapy*; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy; D003925:Diabetic Angiopathies / Q000517:prevention & control; D015525:Fatty Acids, Omega-3 / Q000378:metabolism / Q000627:therapeutic use*; D043371:Fatty Acids, Omega-6 / Q000627:therapeutic use; D006801:Humans; D012016:Reference Values
D001786:Blood Glucose; D015525:Fatty Acids, Omega-3; D043371:Fatty Acids, Omega-6